The drug maker reports second-quarter earnings Tuesday, and investors continue to eye a list of glaring problems.

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

U.S. commercial revenue skyrocketed 93% year over year on phenomenal demand for the company's artificial intelligence (AI)-powered software platforms.

Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...

Palantir recently secured a major victory with the U.S. Army's new Enterprise Agreement that establishes a comprehensive ...

This would indicate a 29% rise in earnings compared to the previous year and a 6% increase in sales when compared to last ...

Q2 2025 Management View Paul Richards, EVP and CFO, reported "For the second quarter, we reported a net income of $0.54 per ...

The best place to start is to determine how the stock is valued, and one of the most popular and effective metrics to help make that judgment is earnings per share, known as EPS. "We use a wide ...

Loews Corporation reported $391 million net income for Q2 2025, with contributions from CNA Financial and Boardwalk Pipelines ...

Management described loan origination targets as repayment-dependent, acknowledging portfolio growth and dividend stability could be at risk if anticipated repayments do not materialize as projected, ...

Nifty 50 EPS projected to grow by 10% in FY26, supported by fiscal measures and sectoral preferences, per Motilal Oswal.

Investors may want to keep close tabs on CHKP stock. During the business week beginning Oct. 28, 2024, Check Point suffered a ...